Hunan Fangsheng Pharm Co Ltd (603998) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million ≈ $13.99 Million USD) by net assets (CN¥1.75 Billion ≈ $256.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Hunan Fangsheng Pharm Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Hunan Fangsheng Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Carriage Services Inc NYSE:CSV	0.102x
CorMedix Inc NASDAQ:CRMD	0.233x
Korea Investment Holdings Co Ltd KO:071055	-0.587x
Getein Biotech Inc SHG:603387	0.034x
Jiangxi Chen Guang New Materials Co Ltd SHG:605399	-0.014x
Caribbean Utilities Company Ltd TO:CUP-U	0.054x
Zhengzhou Qianweiyangchu Food Co Ltd SHE:001215	0.044x
Relmada Therapeutics Inc NASDAQ:RLMD	-0.069x

Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Hunan Fangsheng Pharm Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.80 Billion ≈ $263.81 Million	CN¥384.63 Million ≈ $56.28 Million	0.213x	+89.86%
2024-12-31	CN¥1.73 Billion ≈ $253.87 Million	CN¥194.95 Million ≈ $28.53 Million	0.112x	+103.94%
2023-12-31	CN¥1.59 Billion ≈ $232.48 Million	CN¥87.54 Million ≈ $12.81 Million	0.055x	-72.45%
2022-12-31	CN¥1.51 Billion ≈ $220.66 Million	CN¥301.63 Million ≈ $44.14 Million	0.200x	+40.48%
2021-12-31	CN¥1.30 Billion ≈ $190.76 Million	CN¥185.63 Million ≈ $27.16 Million	0.142x	-23.85%
2020-12-31	CN¥1.27 Billion ≈ $185.22 Million	CN¥236.66 Million ≈ $34.63 Million	0.187x	+38.29%
2019-12-31	CN¥1.20 Billion ≈ $175.95 Million	CN¥162.58 Million ≈ $23.79 Million	0.135x	-14.54%
2018-12-31	CN¥1.11 Billion ≈ $162.84 Million	CN¥176.06 Million ≈ $25.76 Million	0.158x	+925.77%
2017-12-31	CN¥1.04 Billion ≈ $151.83 Million	CN¥16.00 Million ≈ $2.34 Million	0.015x	-87.27%
2016-12-31	CN¥979.69 Million ≈ $143.36 Million	CN¥118.70 Million ≈ $17.37 Million	0.121x	+24.64%
2015-12-31	CN¥931.73 Million ≈ $136.34 Million	CN¥90.57 Million ≈ $13.25 Million	0.097x	-13.08%
2014-12-31	CN¥841.94 Million ≈ $123.20 Million	CN¥94.16 Million ≈ $13.78 Million	0.112x	-64.82%
2013-12-31	CN¥386.85 Million ≈ $56.61 Million	CN¥122.97 Million ≈ $17.99 Million	0.318x	+318.63%
2012-12-31	CN¥318.83 Million ≈ $46.66 Million	CN¥24.21 Million ≈ $3.54 Million	0.076x	-69.88%
2011-12-31	CN¥258.49 Million ≈ $37.83 Million	CN¥65.16 Million ≈ $9.54 Million	0.252x	--

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic

Market Cap

$600.75 Million

CN¥4.11 Billion CNY

Market Cap Rank

#11445 Global

#3280 in China

Share Price

CN¥9.35

Change (1 day)

+0.32%

52-Week Range

CN¥9.32 - CN¥13.01

All Time High

CN¥18.09